REDWOOD CITY, Calif.--(BUSINESS WIRE)--Proteus Digital Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its ingestible sensor for marketing as a medical device ...
Proteus Digital Health published a paper on its ingestible sensor that explains the design of the sensor, the safety tests Proteus completed, and the clinical trials Proteus conducted with 412 ...
REDWOOD CITY, Calif. - Proteus Biomedical Inc., a pioneer in intelligent medicine, entered into an exclusive worldwide license and collaboration agreement with Novartis to develop and commercialize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results